Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects.

Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects. Abstract Text:

    o b betzO B Betz,v m betzV M Betz,a nazarianA Nazarian,m egermannM Egermann,l c gerstenfeldL C Gerstenfeld,t a einhornT A Einhorn,m s vrahasM S Vrahas,m l bouxseinM L Bouxsein,c h evansC H Evans,

    The direct, local, administration of adenovirus carrying human BMP-2 cDNA (Ad.BMP-2) heals critical-sized femoral bone defects in rabbit and rat models. However, the outcome is suboptimal and the technology needs to provide a more reliable and uniform outcome. To this end, we investigated whether the timing of Ad.BMP-2 administration influenced the formation of mineralized tissue within the defect. Critical-sized defects were created in the femora of 28 Sprague-Dawley rats. Animals were injected intralesionally with a single, percutaneous injection of Ad.BMP-2 (4 x 10(8) plaque-forming units) either intraoperatively (day 0) or 24 h (day 1), 5 days or 10 days after surgery. The femora were evaluated 8 weeks after surgery by X-ray, microcomputed tomography, dual-energy X-ray absorptiometry and biomechanical testing. The incidence of radiological union was markedly increased when administration of Ad.BMP-2 was delayed until days 5 and 10, at which point 86% of the defects healed. These time points also provided greater bone mineral content within the defect site and improved the average mechanical strength of the healed bone. Thus, delaying the injection of Ad.BMP-2 until 5 or 10 days after surgery enables a greater percentage of critical-sized, segmental defects to achieve radiological union, producing a repair tissue with enhanced mineralization and greater mechanical strength.

    Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects. Publishing Authors By Initials

    ob betzOB Betz,vm betzVM Betz,a nazarianA Nazarian,m egermannM Egermann,lc gerstenfeldLC Gerstenfeld,ta einhornTA Einhorn,ms vrahasMS Vrahas,ml bouxseinML Bouxsein,ch evansCH Evans,

    For similar peptides: intercellular signaling peptides and proteins: cytokines: transforming growth factor beta research abstracts see: peptides: intercellular signaling peptides and proteins: cytokines: transforming growth factor beta research

    PUBMED ID PMID:

    MEDLINE DATE:

    Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Gene therapy

    VOLUME: 14

    Page Numbers: 1039-44

    Journal Abbreviation: Gene Ther.

    ISSN: 0969-7128

    DAY: 26

    MONTH: 04

    YEAR: 2007

    Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9421525

    Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects. Keywords Mesh Terms:

    KEYWORDS: Transforming Growth Factor beta

    MESH TERMS: metabolism

    Chemical & Substance for Abstract: Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects. Information

    Substance Name: bone morphogenetic protein 2

    Registry Number: 0

    Grant and Affiliation Information for Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects.

    AFFILIATION: Center for Molecular Orthopaedics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY: United States NIAMS

    GRANT: AR 050243-02

    ACRONYM: AR

    MEDLINETA: Gene Ther

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News